Olivia Ventures, Inc. (26)

Browse by Contract Category

Contracts

Securities Purchase Agreement dated November 2, 2022 (Filed With SEC on November 9, 2022)
Open Market Sale AgreementSM , dated August 1, 2022, by and between Compass Therapeutics, Inc. and Jefferies LLC (Filed With SEC on August 1, 2022)
Research and Development Collaboration and License Agreement, dated November 30, 2018, between TRIGR Therapeutics, Inc. and ABL Bio Inc (Filed With SEC on August 16, 2021)
CONSULTING AGREEMENT (Filed With SEC on June 30, 2021)
Sublease Agreement, effective as of December 1, 2020, by and between Roche Diagnostic Operations, Inc. and Compass Therapeutics, Inc (Filed With SEC on March 5, 2021)
Agreement and Plan of Merger, dated June 17, 2020, by and among the Olivia Ventures, Inc., Merger Sub, a Delaware corporation and wholly-owned subsidiary of Olivia Ventures, Inc.,... (Filed With SEC on June 23, 2020)
Registration Rights Agreement dated November 2, 2022 (Filed With SEC on November 9, 2022)
Underwriting Agreement, dated November 1, 2021, by and among Compass Therapeutics, Inc. and SVB Leerink LLC, as representative of the several underwriters named therein (Filed With SEC on November 3, 2021)
Employment Agreement between Compass Therapeutics, Inc. and Vered Bisker-Leib, Ph.D (Filed With SEC on April 19, 2021)
Employment Agreement between Compass Therapeutics, Inc. and Thomas J. Schuetz, M.D., Ph.D (Filed With SEC on April 19, 2021)
Description of Registered Securities (Filed With SEC on March 5, 2021)
Form of Underwriting Agreement (Filed With SEC on November 9, 2020)
Specimen Certificate for Common Stock (Filed With SEC on October 19, 2020)
2020 Stock Option and Incentive Plan (Filed With SEC on June 23, 2020)
Second Amendment to Loan and Security Agreement, dated March 8, 2019, by and between Pacific Western Bank, Inc., Compass Therapeutics, LLC and Compass Therapeutics Advisors, Inc (Filed With SEC on June 23, 2020)
First Amendment to Loan and Security Agreement, dated September 26, 2018, by and between Pacific Western Bank, Inc., Compass Therapeutics, LLC and Compass Therapeutics Advisors,... (Filed With SEC on June 23, 2020)
Loan and Security Agreement, dated March 30, 2018, by and between Pacific Western Bank, Inc., Compass Therapeutics, LLC and Compass Therapeutics Advisors, Inc (Filed With SEC on June 23, 2020)
Amended and Restated Collaboration Agreement, dated February 11, 2015, by and between Adimab LLC and Kairos Biologics Foundation LLC (Filed With SEC on June 23, 2020)
Subscription Agreement, dated June 19, 2020, by and between Compass Therapeutics, Inc. and the investors party thereto (Filed With SEC on June 23, 2020)
Registration Rights Agreement, dated June 19, 2020, by and among the Compass Therapeutics, Inc. and the parties thereto (Filed With SEC on June 23, 2020)
Form of Pre-Merger Indemnification Agreement (directors and executive officers) (Filed With SEC on June 23, 2020)
Form of Indemnification Agreement (executive officers) (Filed With SEC on June 23, 2020)
Form of Indemnification Agreement (directors) (Filed With SEC on June 23, 2020)
Offer letter, dated November 8, 2017, between Vered Bisker-Leib and Compass Therapeutics LLC (Filed With SEC on June 23, 2020)
2020 Senior Executive Cash Incentive Bonus Plan (Filed With SEC on June 23, 2020)
Third Amendment to Loan and Security Agreement, dated October 29, 2019, by and between Pacific Western Bank, Inc., Compass Therapeutics, LLC and Compass Therapeutics Advisors, Inc (Filed With SEC on June 23, 2020)